TNX-801 is up to 100,000-fold less virulent than live smallpox vaccine strains and a single dose provides robust immunogenicity and protection against mpox and rabbitpox (more than one year) in ...

NEW YORK, NY, USA I July 8, 2025 I Myrtelle Inc. (“Myrtelle” or the “Company”), a pioneering clinical-stage gene therapy company dedicated to revolutionizing treatment for neurodegenerative diseases, ...

today announced the official launch of commercial-stage manufacturing for its first-in-class oligotrophic recombinant adeno-associated virus (rAAV) gene therapy product, developed specifically for ...

The WHO has classified XFG or ‘Stratus’ as a variant under monitoring. It may well become the dominant variant globally very ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...

A recombinant flu vaccine (Flublok) contains no eggs and was recently approved for use in individuals aged 9 years or older ...

Two AS01-adjuvanted vaccines for different pathogens -- the respiratory syncytial virus (RSV) vaccine (Arexvy) and the ...

Bio-Techne Corporation (NASDAQ:TECH) is one of the best S&P 500 stocks with huge upside potential. On June 24, Bio-Techne ...

Researchers have developed the downstream section of a new streamlined production method for an emerging virus class.

Background: Oncolytic viruses have shown an excellent safety profile and can initiate antitumour immunity through in-situ tumor lysis and systemic immune response, thereby gaining significant ...

Amplicons for amp R are shown in red, pAAV-ZsGreen1 backbone unique in green, E4 in blue, and rep in yellow. rAAV, recombinant adeno-associated virus. Credit: Human Gene Therapy (2025).